Surgical Staging

In general, cancers are divided into categories or stages, with the assignment with a stage based on the risk for recurrence. For vulvar cancer the final stage depends on the pathologic review of the surgical specimens from the vulva and regional lymph nodes.

Stage IA: These lesions do not require a regional lymph node evaluation because of the low risk of metastasis.

Stage 1B: These tumors have deeper invasion (great than 1mm), but the regional lymph nodes are negative. These patients remain in Stage 1 category since they have a no risk for recurrence.

Stage II: The tumors have a local extension to the urethra, anus or vagina with negative lymph nodes. These patients have a lower risk of recurrence than patients described as Stage III.

Stage III: This stage includes patients with lymph node metastases regardless of size, location or extension of the primary vulvar tumor. The presence and extent of lymph node involvement is the single most important factor in the determining the risk of recurrence.

Spotlight

CURE® Magazine Teams Up with the Foundation for Women’s Cancer in Advocacy Spotlight Partnership Program. Read more

Awareness

Read this NY Times piece featuring Nt’l Race Host Committee member Megan Neforos: click here

Research

The 2015-2016 Research Grants and Awards will be announced in Summer, 2015. For more information, click here.

Education

The next Gynecologic Cancer Survivors Course is Sept. 12 in Duarte, Calif. For more information, click here.